Because SFT is a mesenchymal tumor, immunohistochemical staining is positive for CD34 and vimentin, and negative for mesothelial cell-derived cytokeratin and epithelial membrane antigen. This evidence concerns the gene CD34 and mesenchymal cell neoplasm.